You are in : Home » Results & submissions » Select UOA » 1 - Clinical Medicine » View submission: University of Oxford » Outputs » Detail

Output details

1 - Clinical Medicine

University of Oxford

Return to search Previous output Next output

Output 0 of 0 in the submission

Article title

Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study.

Type

D - Journal article

DOI

10.1002/art.27348

Title of journal

Arthritis Rheum

Article number

Volume number

Issue number

First page of article

917

ISSN of journal